General Information of the Protein
| Protein ID |
PT00951
|
||||
|---|---|---|---|---|---|
| Protein Name |
Proto-oncogene tyrosine-protein kinase receptor Ret
|
||||
| Secondarily Protein Name |
Cadherin family member 12
Proto-oncogene c-Ret
|
||||
| Gene Name |
RET
|
||||
| Secondarily Gene Name |
CDHF12
CDHR16
PTC
RET51
|
||||
| Sequence |
MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQEDTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENRPPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAPTFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNRNLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCSTLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGRCEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLCDELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRRDYLDLAASTPSDSLIYDDGLSEEETPLVDCNNAPLPRALPSTWIENKLYGMSDPNWPGESPVPLTRADGTNTGFPRYPNDSVYANWMLSPSAAKLMDTFDS
Show/Hide
|
||||
| Organism |
Homo sapiens, Human
|
||||
| Protein Classification |
Enzyme
>
Kinase
>
Protein Kinase
>
TK protein kinase group
>
Tyrosine protein kinase Ret family
|
||||
| Function |
Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation upon binding with glial cell derived neurotrophic factor family ligands. Phosphorylates PTK2/FAK1. Regulates both cell death/survival balance and positional information. Required for the molecular mechanisms orchestration during intestine organogenesis; involved in the development of enteric nervous system and renal organogenesis during embryonic life, and promotes the formation of Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue. Modulates cell adhesion via its cleavage by caspase in sympathetic neurons and mediates cell migration in an integrin (e.g. ITGB1 and ITGB3)-dependent manner. Involved in the development of the neural crest. Active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage. Acts as a dependence receptor; in the presence of the ligand GDNF in somatotrophs (within pituitary), promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF. Regulates nociceptor survival and size. Triggers the differentiation of rapidly adapting (RA) mechanoreceptors. Mediator of several diseases such as neuroendocrine cancers; these diseases are characterized by aberrant integrins-regulated cell migration. Mediates, through interaction with GDF15-receptor GFRAL, GDF15-induced cell-signaling in the brainstem which induces inhibition of food-intake. Activates MAPK- and AKT-signaling pathways (PubMed:28846097, PubMed:28953886, PubMed:28846099). Isoform 1 in complex with GFRAL induces higher activation of MAPK-signaling pathway than isoform 2 in complex with GFRAL (PubMed:28846099).
Show/Hide
|
||||
| Uniprot ID |
Show/Hide
|
||||
| Ensembl ID | |||||
| HGNC ID | |||||
| Subcellular Location |
Cell membrane
Endosome membrane
|
||||
Map of Molecular Bioactivity Related to the Protein
|
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000077 , Ba/F3
Cell Line ID: CL000006 , HEK293
Cell Line ID: CL000012 , Sf21
Cell Line ID: CL000013 , Sf9
Cell Line ID: CL000289 , SK-N-SH
Cell Line ID: CL000425 , TT
Biochemical Assays
Clinical Information about the Protein
Target 1 ( Proto-oncogene c-Ret (RET) )
| Target Type | Successful Target | ||||
|---|---|---|---|---|---|
| Disease | 6 Target-related Diseases | 6 | |||
| 1 | Acute lymphoblastic leukaemia [ICD-11: 2A85] | ||||
| 2 | Metastatic colorectal cancer [ICD-11: 2B91] | ||||
| 3 | Thrombocytopenia [ICD-11: 3B64] | ||||
| 4 | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||
| 5 | Inflammatory bowel disease [ICD-11: DD72] | ||||
| 6 | Non-small-cell lung cancer [ICD-11: 2C25.Y] | ||||
| Approved Drug(s) | 5 Approved Drugs | 5 | |||
| 1 | Ponatinib | Approved | |||
| 2 | Regorafenib | Approved | |||
| 3 | Romiplostim | Approved | |||
| 4 | Vandetanib | Approved | |||
| 5 | Pralsetinib | Approved | |||
| Clinical Trial Drug(s) | 4 Clinical Trial Drugs | 4 | |||
| 1 | CEP-32496 | Phase 1/2 | |||
| 2 | MGCD516 | Phase 2/3 | |||
| 3 | GSK3179106 | Phase 1 | |||
| 4 | tamatinib | Clinical trial | |||
Target 2 ( RET G691S mutant (RET G691S) )
| Target Type | Patented-recorded Target | ||||
|---|---|---|---|---|---|
Target 3 ( RET M918T mutant (RET M918T) )
| Target Type | Patented-recorded Target | ||||
|---|---|---|---|---|---|
Target 4 ( RET S891A mutant (RET S891A) )
| Target Type | Patented-recorded Target | ||||
|---|---|---|---|---|---|
Target 5 ( RET V804L mutant (RET V804L) )
| Target Type | Patented-recorded Target | ||||
|---|---|---|---|---|---|
Target 6 ( RET V804M mutant (RET V804M) )
| Target Type | Patented-recorded Target | ||||
|---|---|---|---|---|---|
Target 7 ( RET Y791F mutant (RET Y791F) )
| Target Type | Patented-recorded Target | ||||
|---|---|---|---|---|---|
Similar Protein(s) and Bioactivity Statistics
50% Identity
| Protein ID | Protein Name | Protein Organism | |
| PT06733 | Proto-oncogene tyrosine-protein kinase receptor Ret | Mus musculus, Mouse | |
|---|---|---|---|